These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36573458)

  • 1. LOXL2 reduces 5-FU sensitivity through the Hedgehog/BCL2 signaling pathway in colorectal cancer.
    Qiu Z; Qiu S; Mao W; Lin W; Peng Q; Chang H
    Exp Biol Med (Maywood); 2023 Mar; 248(6):457-468. PubMed ID: 36573458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNHG15 promotes chemoresistance and glycolysis in colorectal cancer.
    Li M; Sun S; Bian Z; Yao S; Liu M; You X; Li M
    Pathol Res Pract; 2023 Jun; 246():154480. PubMed ID: 37148838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
    Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis.
    Lai Q; Li Q; He C; Fang Y; Lin S; Cai J; Ding J; Zhong Q; Zhang Y; Wu C; Wang X; He J; Liu Y; Yan Q; Li A; Liu S
    Aging (Albany NY); 2020 Jul; 12(16):16270-16293. PubMed ID: 32688344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysyl oxidase-like 2 is highly expressed in colorectal cancer cells and promotes the development of colorectal cancer.
    Cui X; Wang G; Shen W; Huang Z; He H; Cui L
    Oncol Rep; 2018 Aug; 40(2):932-942. PubMed ID: 29845296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
    Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
    BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced
    Wang F; Zhao L; Zhang J; Meng Z; Zhou C; Wang G; Liu Y; Li M; Xi J; Niu W; Wang G
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
    Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1.
    Li C; Lu K; Yang C; Du W; Liang Z
    J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircDDX17 reduces 5-fluorouracil resistance and hinders tumorigenesis in colorectal cancer by regulating miR-31-5p/KANK1 axis.
    Ren TJ; Liu C; Hou JF; Shan FX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1743-1754. PubMed ID: 32141542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial metabolite sodium butyrate enhances the anti-tumor efficacy of 5-fluorouracil against colorectal cancer by modulating PINK1/Parkin signaling and intestinal flora.
    Li Y; He P; Chen Y; Hu J; Deng B; Liu C; Yu B; Dong W
    Sci Rep; 2024 Jun; 14(1):13063. PubMed ID: 38844824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
    Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
    Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
    Zhang L; Zhou R; Zhang W; Yao X; Li W; Xu L; Sun X; Zhao L
    J Exp Clin Cancer Res; 2019 Mar; 38(1):120. PubMed ID: 30850009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K/Akt signaling axis.
    Chen H; Deng J; Hou TW; Shan YQ
    J Ethnopharmacol; 2024 May; 325():117907. PubMed ID: 38342156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
    Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
    BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.